je.st
news
Home
› Premarket Biotech Digest: Gilead And HCV Drug Pricing, Relypsa Rumors, Amgen-Merck Collaboration
Premarket Biotech Digest: Gilead And HCV Drug Pricing, Relypsa Rumors, Amgen-Merck Collaboration
2015-12-07 17:45:48| Biotech - Topix.net
Our regular management interview will be held on our subscription panel today at 11am EST with Dr Todd Brady, MD, PhD, CEO of Aldeyra . Please buy a discounted subscription to participate in the panel discussion, and other discussions held regularly for subscribers.
Tags: drug
pricing
collaboration
digest
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||